Continuous manufacturing technologies in upstream pharmaceutical supply chains: Combining engineering and managerial criteria
Contributor(s):: Aulakh, PK, Settanni, E, Srai, JS
The COVID-19 pandemic exposed vulnerabilities in upstream pharmaceutical supply chains (PSC). One is that the global supply of active pharmaceutical ingredients (APIs) is overly dependent on few locations and large-scale batch manufacturing. Regulators hope to enable more dependable location...